Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Metabolomic characterization of metabolic phenotypes in OA

Increasing evidence implicates metabolic dysfunction in the development and progression of osteoarthritis (OA). Large-scale 'omics' studies, particularly metabolomics, have the potential to answer many questions relating to the pathogenesis of so-called 'metabolic OA' and other OA phenotypes, and could be key to the identification of novel biomarkers for these conditions.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Development of analytical platforms for OA biomarker discovery and validation.


  1. 1

    Adams, S. B. et al. Global metabolic profiling of human osteoarthritic synovium. Osteoarthritis Cartilage 20, 64–67 (2012).

    Article  Google Scholar 

  2. 2

    Ruiz-Romero, C. & Blanco, F. J. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Osteoarthritis Cartilage 18, 500–509 (2010).

    CAS  Article  Google Scholar 

  3. 3

    Nicholson, J. K. & Wilson, I. D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2, 668–676 (2003).

    CAS  Article  Google Scholar 

  4. 4

    Zhai, G. et al. Serum branched-chain amino acid to histidine ratio: a novel metabolomics biomarker of knee osteoarthritis. Ann. Rheum. Dis. 69, 1227–1231 (2010).

    CAS  Article  Google Scholar 

  5. 5

    Lamers, R. J. et al. Identification of an urinary metabolite profile associated with osteoarthritis. Osteoarthritis Cartilage 13, 762–768 (2005).

    CAS  Article  Google Scholar 

  6. 6

    Blanco, F. J., Rego, I. & Ruiz-Romero, C. The role of mitochondria in osteoarthritis. Nat. Rev. Rheumatol. 7, 161–169 (2011).

    CAS  Article  Google Scholar 

  7. 7

    Berenbaum, F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann. Rheum. Dis. 70, 1354–1356 (2011).

    Article  Google Scholar 

  8. 8

    Feder, J. et al. Parental diabetes status reveals association of mitochondrial DNA haplogroup J1 with type 2 diabetes. BMC Med. Genet. 10, 60 (2009).

    Article  Google Scholar 

  9. 9

    Niemi, A. K. et al. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum. Genet. 112, 29–33 (2003).

    CAS  Article  Google Scholar 

  10. 10

    Yang, T. L. et al. Genetic association study of common mitochondrial variants on body fat mass. PLoS ONE 6, e21595 (2011).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Francisco J. Blanco.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Blanco, F., Ruiz-Romero, C. Metabolomic characterization of metabolic phenotypes in OA. Nat Rev Rheumatol 8, 130–132 (2012).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing